Therefore, we performed a Kaplan-Meier analysis using overall survival in pan-cancer and found that GBP5 was associated with a better short-term prognosis in a majority of cancers such as STAD (Stomach adenocarcinoma), COAD, and READ (Rectum adenocarcinoma) (Figures 3A–C, Supplementary Figure S5). Here, GBP5 is linked to rectum adenocarcinoma.